Acquired amegakaryocytic thrombocytopenic purpura with literature review

Joint Event on 11^th WORLD HEMATOLOGY AND ONCOLOGY CONGRESS & 47^th WORLD CONGRESS ON NURSING CARE

July 24-25, 2019 | Rome, Italy

Prabu Pandurangan

Apollo Hospitals, India

Keynote: J Blood Disord Treat

Abstract :

Acquired amegakaryocytic thrombocytopenic purpura (AATP) is an uncommon disorder with thrombocytopenia and selectively suppressed megakaryopoiesis, often mistaken as immune thrombocytopenic purpura (ITP). It usually does not respond to steroids, and bone marrow examination shows complete absence of megakaryocytes. The treatment and prognosis of AATP vary greatly from ITP; therefore, it is important to diagnose and treat this condition early, as it can progress rapidly to complete bone marrow failure. In this case report, we report a patient with AATP responded well to cyclosporine therapy.

Biography :

Pandurangan Prabu had completed his MBBS in the year 1992 and had completed his training in Hematology in May 2006. He was a consultant haematologist from 2006 to 2010 at UK. Currently, he is a senior consultant haematologist at Apollo Hospitals, India. His main area of work includes the diagnosis and management of haematological malignancies and bleeding disorders. He holds his expertise in autologous and allogeneic haematopoietic stem cell transplantation.

E-mail: drprabu.p@gmail.com